Arbutus Biopharma Corporation ABUS Change in Deferred Revenue
Change in Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's change in deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's change in deferred revenue?
- Arbutus Biopharma Corporation (ABUS) reported change in deferred revenue of $0 in Q1 2026.
- How has Arbutus Biopharma Corporation's change in deferred revenue changed year-over-year?
- Arbutus Biopharma Corporation's change in deferred revenue increased by 100.0% year-over-year, from -$812K to $0.
- What does change in deferred revenue mean?
- Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.